EP3580208

2-(3-(1H-BENZO[D]IMIDAZOL-1-YL)PROPYL)PIPERIDIN-3-OL DERIVATIVES AND RELATED COMPOUNDS AS PRS INHIBITORS FOR TREATING E.G. CANCER

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    7.2.2018
  • EP published:
    1.9.2021
  • EP application number:
    18750794.2
  • Max expiry date:
    6.2.2038
  • Title:
    2-(3-(1H-BENZO[D]IMIDAZOL-1-YL)PROPYL)PIPERIDIN-3-OL DERIVATIVES AND RELATED COMPOUNDS AS PRS INHIBITORS FOR TREATING E.G. CANCER

Timeline

Today
7.2.2018EP application
1.9.2021EP Publication

Owner

  • Name:
    Daewoong Pharmaceutical Co., Ltd.
  • Address:
    35-14, Jeyakgongdan 4-gil Hyangnam-eup, Hwaseong-si, Gyenoggi-do 18623, KR

Inventor

  • Name:
    LEE, Bong-Yong
  • Address:
    Seoul 06701, KR
  • Name:
    CHO, Min-Jae
  • Address:
    Yongin-si Gyeonggi-do 16898, KR
  • Name:
    LEE, Hyung-Geun
  • Address:
    Yongin-si Gyeonggi-do 17027, KR
  • Name:
    JUNG, Myung-gi
  • Address:
    Seongnam-si Gyeonggi-do 13584, KR
  • Name:
    OH, Yunju
  • Address:
    Yongin-si Gyeonggi-do 16833, KR

Priority

  • Number:
    20170016971
  • Date:
    7.2.2017
  • Country:
    KR

Classification

  • Categories:
    C07D 401/06, C07D 401/14, C07D 403/06, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, A61K 31/454, A61K 31/4184, A61P 35/00, A61P 37/06, A61P 29/00

Upload documents